1. Field of the Invention
This invention generally relates to systems to secure tissue, more particularly to tissue securement systems for treatment of obstructive sleep apnea.
2. Related Art
Obstructive sleep apnea (OSA) is caused by a blockage of the airway, which usually occurs when the soft tissue in the throat collapses and closes during sleep. According to the National Institutes of Health, OSA affects more than twelve million Americans. During each apnea event, the brain briefly arouses the sufferer in order to initiate the resumption of breathing. This type of sleep, however, is extremely fragmented and of poor quality. When left untreated, OSA may result in high blood pressure, cardiovascular disease, weight gain, impotency, headaches, memory problems, job impairment, and motor vehicle crashes. Despite the seriousness of OSA, a general lack of awareness among the public and healthcare professionals results in the vast majority of OSA sufferers remaining undiagnosed and untreated.
In the human body, an air filled space between the nasal cavity and the larynx is referred to as the upper airway. The most critical part of the upper airway associated with sleep disorders is the pharynx. The pharynx has three different anatomical levels. The nasopharynx is the upper portion of the pharynx located in the back of the nasal cavity. The oropharynx is the intermediate portion of the pharynx containing the soft palate, the epiglottis, and the curve at the back of the tongue. The hypopharynx is the lower portion of the pharynx located below the soft tissue of the oropharynx. The oropharynx is the section of the pharynx that is most likely to collapse due to the high prevalence of soft tissue structure, which leaves less space for airflow. The hypopharynx lies below the aperture of the larynx and behind the larynx, and extends to the esophagus.
As is well known to those skilled in the art, the soft palate and the tongue are both flexible structures. The soft palate provides a barrier between the nasal cavity and the mouth. In many instances, the soft palate is longer than necessary and it extends a significant distance between the back of the tongue and the posterior pharyngeal wall.
Although the muscles relax throughout the body during sleep, most of the muscles of the respiratory system remain active. During inhalation, the diaphragm contracts and causes negative pressure to draw air into the nasal cavity and the mouth. The air then flows past the pharynx, through the trachea and into the lungs. The negative pressure causes the tissue of the upper airway to deform slightly, which narrows the airway passage. In apneic patients, the soft palate, the tongue, and/or the epiglottis collapse against the posterior pharyngeal wall to block airflow into the trachea. As the airway narrows, airflow through the pharynx becomes turbulent which causes the soft palate to vibrate, generating a sound commonly known as snoring.
During sleep, humans typically experience brief obstructions of airflow and/or small decreases in the amount of airflow into the trachea and lungs. An obstruction of airflow for more than ten seconds is referred to as apnea. A decrease in airflow by more than fifty percent is referred to as hypopnea. The severity of sleep disorders is measured by the number of apneas and hypopneas that occur during every hour of sleep.
If apnea or hypopnea occurs more than five times per hour, most medical personnel diagnose the individual as having an upper airway resistance problem. Many of these patients often exhibit symptoms related to sleep disorders including sleepiness during the day, depression, and difficulty concentrating.
Individuals having ten or more episodes of apnea or hypopnea during every hour of sleep are officially classified as having obstructive sleep apnea syndrome. As the airway is obstructed, the individual makes repeated attempts to force inhalation. Many of these episodes are silent and are characterized by movements of the abdomen and chest wall as the individual strains to draw air into the lungs. Typically, episodes of apnea may last a minute or more. During this time, oxygen levels in the blood will decrease. Ultimately, the obstruction may be overcome by the individual generating a loud snore or awakening with a choking feeling.
When an individual is awake, the back of the tongue and the soft palate maintain their shape and tone due to their respective internal muscles. As a result, the airway through the pharynx remains open and unobstructed. During sleep, however, the muscle tone decreases and the posterior surface of the tongue and the soft palate become more flexible and distensible. Without normal muscle tone to keep their shape and to keep them in place either alone or as a group, the posterior surface of the tongue, the epiglottis, and the soft palate tend to easily collapse to block the airway.
U.S. Pat. No. 7,367,340 describes one approach to treat sleep apnea and is directed to the use of an element that is anchored to the mandible and is capable of applying force within the tongue to prevent the tongue from collapsing during sleep. In the embodiments described, the device consists of an element that is attached to the mandible though drilling of the mandible to provide a rigid point of fixation. The method of attachment risks damaging the dental anatomy and nerve structures within the mandible.
A commercial implant system, sold under the trademark REPOSE™ by InfluENT of Concord, N.H., uses a titanium screw that is inserted into the posterior aspect of the mandible at the floor of the mouth. A loop of suture is passed through the tongue base and attached to the mandibular bone screw. The REPOSE™ procedure achieves a suspension or hammock of the tongue base making it less likely for the base of the tongue to prolapse during sleep. Due to the high activity of the tongue during wakefulness, however, the suture component of this device may act as a cutting element within the tongue, causing device trans-location and ultimately a loss of efficacy of the procedure thereby requiring subsequent removal. Additionally, the fiber is placed within the tongue through the combination of a sterile and non-sterile approach. An incision is made within the sub-mental space to provide access to the infra-mandibular region to place the screw. Once the screw is attached to the mandible, the fiber element is passed into the tongue through the sub-mental musculature, through the genioglossus and exits out of the mucosal surface of the tongue into the contaminated oral cavity. This passage is accomplished through the use of a linear designed suture passer that grasps the fiber, through the use of a jaw like element, and forces it through the tongue in a straight path. Upon exiting in the oral cavity, the fiber is then passed laterally in a sub mucosal pass through the original puncture formed by the curved suture passer which is essentially an eyed needle.
The use of the eyed needle results in the folding of the fiber in half about the eyelet of the needle, thereby increasing, in an irregular fashion, the projected diameter/dissecting cross section of the device. This increase in projected dissection surfaces results in the creation of a larger hole than is necessary for the single strand of fiber that is to be deposited within the tissue tract.
Furthermore, the use of the jawed type linear suture passer also results in an increased projected cross sectional dissecting surface. The fiber is laid into the jaw and is clamped. In the best case scenario, the jaw resultant projected dissecting tissue surface consists of the cross sectional area of the fiber lying alongside the cross sectional area of the shaft of the linear suture passer.
Another commercially available tongue suspension device, developed by ASPIRE Medical, is named the ADVANCE System. It's similar to the REPOSE suture suspension system for the tongue base in that it utilizes a bone screw in the mandible, but has the advantage of being adjustable. The device utilizes a flexible shape memory anchor within the tongue that is shaped similar to a grappling hook to engage the tissue within the tongue base. It's placed through a small incision in the sub-mental region and the suture is attached to a spool-like component attached to the mandible. Two to four weeks after healing, a small incision is made under the chin and a screw is turned to tighten the suture, thus pulling the device forward. While the device provides a simplified installation technique from within the sterile space, the anchors may suffer from a high rate of device fracture and failure due to loading within the tongue musculature. Additionally, the risk of damage to the teeth or the nerve roots for the teeth is similar to the RESPOSE bone screw.
In spite of the above advances in tongue suspension devices, there remains a need for a tongue suspension method and suture passer device that enables the passage of fiber with minimal increase in the size of the dissected tunnel formed in the traverse of the fiber.
a-c depict elements of one method of a tissue securement system particularly directed toward the threading of fiber through an eyelet of a linear suture passer and the subsequent passing of the threaded fiber through tissue.
The present invention relates generally to a system for the securement of tissue comprising:
a) a securement fiber comprising a distal end and a proximal end, the distal end further comprising a distal connector and the proximal end further comprising a proximal connector;
b) a needle comprising a proximal end and a distal end, the distal end further comprising a tissue piercing surface and the proximal end comprising a connector, the connector being releasably engageable with the distal connector of the fiber; and
c) a tissue passer comprising a proximal end and a distal end, the distal end releasably engageable with the distal and proximal connectors of the fiber.
This invention also generally relates to tissue securement methods comprising the steps of:
a) piercing the tissue at a first puncture point with a needle having proximal and distal ends that is attached to a securement fiber, the fiber having a first end and a second end with the attachment of the needle to the fiber occurring at the first end of the fiber and the proximal end of the needle;
b) exiting the tissue at a second puncture point with the needle and securement fiber;
c) releasing the needle from the securement fiber while ensuring that the first and second ends of the fiber remain outside of the tissue at the first and second puncture points;
d) passing a fiber passer from a first entry point through the tissue and out of the tissue at the first puncture point;
e) attaching the distal tip of the fiber passer with the second end of the fiber outside of the tissue at the first puncture point;
f) drawing the fiber attached to the fiber passer through the tissue at the first puncture point by pulling the fiber passer with attached fiber through and out of the first entry point;
g) releasing the fiber from the fiber passer;
h) passing the fiber passer from a second entry point through the tissue and out of the tissue at the second puncture point;
i) attaching the distal tip of the fiber passer with the first end of the fiber outside of the tissue at the second puncture point;
j) drawing the fiber attached to the fiber passer through the tissue at the second puncture point by pulling the fiber passer with attached fiber through and out of the second entry point; and
k) releasing the fiber from the fiber passer; and
l) attaching the fiber ends at the first and second entry points to at least one anchor or tying the fiber ends together.
In preferred embodiments, the systems and methods of this invention relate to securement of the tongue.
The systems and methods of this invention provide at least the following advantages. The connector features on the fiber ends enable the use of releasable needles, eliminates the need to thread the suture through a snaring/eyed needle type arrangement, and minimizes the tissue tract diameter for the later passing of the fiber through tissue. The hook type element on the suture passer allows passes through tissue minimizing the dragging or traumatizing of tissue, permits quick connection to connector features on the fibers ends, and in combination with connector features on the fiber, minimizes the diameter of the tissue tract by ensuring trailing arrangement of the fiber without having the fiber being folded over. The releasable needle enables easy attachment/detachment from the fiber and ensures that the trailing arrangement of the fiber without folding over the fiber to minimize the diameter of the fiber tract through the tissue.
The present invention relates to a tissue securement system that is able to be placed with minimal tissue trauma. The system consists of three key functional components. The system includes a suspension fiber that has modified ends, a releasable needle, and a linear suture passer. The releasable needle and linear suture passer are designed to engage with the modified ends of the suspension fiber.
As used herein, the terms “suture” and “fiber” may be used interchangeably. Additionally, the terms “suture passer”, “fiber passer” and “tissue passer” are intended to be used interchangeably.
While the connectors 22 may be added as separate elements affixed to the ends of the fiber as described above, it would be appreciated by those of skill in the art that connectors 22 may be created at the ends of the fiber directly through any number of means, including but not limited to: i) forming eyelets at the ends of the fiber by bending back an end of the fiber and knotting the fiber end with the fiber to form an eyelet, or, in the case of a multifilament fiber, bending back an end of a multifilament fiber and then splicing the end into and among the filaments of the fiber at a distance sufficient from the end of the fiber to form an eyelet; ii) reshaping the fiber ends through mechanical means such as machining, cutting, bending, etc. or iii) shaping the fiber ends into appropriate geometries through the use of energy based forming such as RF tipping, thermal compression molding, ultrasonic forming and other such methods. For example, in the case of thermoplastic resin based fibers, it may desirable to form the tip of the fiber into a conical barb form or eyelet form for engagement with the suture passer. The free end of the fiber is placed within a forming die cavity that is shaped to the final desired geometry. As pressure is applied to the fiber, the thermoplastic resin exceeds the melting point of the material and is reshaped to the final cavity form. The fiber is subsequently removed from the form after sufficient time has occurred for cooling of the fiber material below its melting point. In the case of thermoset resins, or other non-formable materials, the fiber may be produced as an oversized form. The fiber may then be placed into stamping die that is capable punching out the final form of the fiber with the associated connector end geometry.
Examples of suitable materials for fiber 20 component useful with this invention are any non-absorbable biocompatible suture material. Suitable non-absorbable materials for use in the present invention include, but are not limited to, cotton, linen, silk, polyamides (polyhexamethylene adipamide (nylon 66), polyhexamethylene sebacamide (nylon 610), polycapramide (nylon 6), polydodecanamide (nylon 12) and polyhexamethylene isophthalamide (nylon 61) copolymers and blends thereof), polyesters (e.g. polyethylene terephthalate, polybutyl terephthalate, copolymers and blends thereof), fluoropolymers (e.g. polytetrafluoroethylene and polyvinylidene fluoride) Poly (hexafluoropropylene-VDF), polyaryletherketones, polyolefins (e.g. polypropylene including isotactic and syndiotactic polypropylene and blends thereof, as well as, blends composed predominately of isotactic or syndiotactic polypropylene blended with heterotactic polypropylene and/or polyethylene (such as is described in U.S. Pat. No. 4,557,264 issued Dec. 10, 1985, assigned to Ethicon, Inc., hereby incorporated by reference in its entirety) and combinations thereof.
In the event that a temporary suspension is desirable, such as in the case of trauma, or radical surgical interventions that may cause swelling of the tongue and associated tissues, or in other locations such as urethra suspension, absorbable fibers may be desirable to provide temporary support until edema/swelling has been reduced. Suitable absorbable materials for use as filaments and/or yarns include, but are not limited to, aliphatic polyesters which include but are not limited to homopolymers and copolymers of lactide (which includes lactic acid d-, l- and meso lactide), glycolide (including glycolic acid), ε-caprolactone, p-dioxanone (1,4-dioxan-2-one), trimethylene carbonate (1,3-dioxan-2-one), alkyl derivatives of trimethylene carbonate, δ-valerolactone, β-butyrolactone, γ-butyrolactone, ε-decalactone, hydroxybutyrate, hydroxyvalerate, 1,4-dioxepan-2-one (including its dimer 1,5,8,12-tetraoxacyclotetradecane-7,14-dione), 1,5-dioxepan-2-one, 6,6-dimethyl-1,4-dioxan-2-one and polymer blends thereof.
Non-limiting examples of suture passer tip designs that may be utilized with the previously disclosed fiber connector ends include conical barbs, flat barbs for joining with fibers having eyeleted ends, female detent pockets, eyelets, hook-like features, quick connect type sleeve arrangements, vacuum wells/surfaces, jaw features, passive magnetic tips, energy based magnetic tips, or magnetic combined with alignment features such as conical ends and receptor geometries.
In use, the system of this invention is capable of securing various types of tissue while minimizing trauma to the tissue compared with tissue securement systems of the prior art.
The tissue securement method using the system of this invention is illustrated in the following figures. While the following method is described for securement of a tongue in a tongue suspension procedure, it should be appreciated by one of skill in the art that the method described is equally applicable to securement or suspension of other types of tissue.
Referring to
Subsequently, once both ends of fiber 20 are pulled through the musculature and out of submental incision 52, the connector ends 22 are cut off or removed as depicted in
Once the connectors 22 have been removed, tension is applied to the free ends of fiber 20 to apply the appropriate suspension of the tongue. The free ends of fiber 20 may either be tied to themselves, tied to at least one anchor or may be engaged with a clamping/clipping structure. Common anchoring points for the free ends of fiber 20 include but are not limited to bone or soft tissue. In the case of tongue suspensions, anchoring to the mandible bone such done in the REPOSE and ADVANCE anchoring systems are contemplated. Also anchoring at least one end of the fiber to mesh implanted in soft tissue is contemplated.
It should be understood that the foregoing disclosure and description of the present invention are illustrative and explanatory thereof and various changes in the size, shape and materials as well as in the description of the preferred embodiment may be made without departing from the spirit of the invention.
Number | Name | Date | Kind |
---|---|---|---|
2705492 | Chandler | Apr 1955 | A |
3123077 | Alcamo | Mar 1964 | A |
3378010 | Codling et al. | Apr 1968 | A |
4024855 | Bucalo | May 1977 | A |
4069825 | Akiyama | Jan 1978 | A |
4091816 | Elam | May 1978 | A |
4290763 | Hurst | Sep 1981 | A |
4523584 | Lynch | Jun 1985 | A |
4557264 | Hinsch | Dec 1985 | A |
4839215 | Starling et al. | Jun 1989 | A |
4881939 | Newman | Nov 1989 | A |
4950285 | Wilk | Aug 1990 | A |
5053047 | Yoon | Oct 1991 | A |
5067485 | Cowen | Nov 1991 | A |
5123913 | Wilk et al. | Jun 1992 | A |
5192271 | Kalb et al. | Mar 1993 | A |
5192274 | Bierman | Mar 1993 | A |
5269783 | Sander | Dec 1993 | A |
5284161 | Karell | Feb 1994 | A |
5311028 | Glavish | May 1994 | A |
5393984 | Glavish | Feb 1995 | A |
5483077 | Glavish | Jan 1996 | A |
5484444 | Braunschweiler et al. | Jan 1996 | A |
5485444 | Kühn et al. | Jan 1996 | A |
5609559 | Weitzner | Mar 1997 | A |
5683417 | Cooper | Nov 1997 | A |
5704895 | Scott et al. | Jan 1998 | A |
5792067 | Karell | Aug 1998 | A |
5843077 | Edwards | Dec 1998 | A |
5931855 | Buncke | Aug 1999 | A |
6161541 | Woodson | Dec 2000 | A |
6190401 | Green et al. | Feb 2001 | B1 |
6241747 | Ruff | Jun 2001 | B1 |
6250307 | Conrad et al. | Jun 2001 | B1 |
6348156 | Vishnoi et al. | Feb 2002 | B1 |
6408851 | Karell | Jun 2002 | B1 |
6431174 | Knudson et al. | Aug 2002 | B1 |
6432437 | Hubbard | Aug 2002 | B1 |
6457472 | Schwartz et al. | Oct 2002 | B1 |
6513530 | Knudson et al. | Feb 2003 | B2 |
6523542 | Knudson et al. | Feb 2003 | B2 |
6578580 | Conrad et al. | Jun 2003 | B2 |
6589549 | Shih et al. | Jul 2003 | B2 |
6599310 | Leung et al. | Jul 2003 | B2 |
6627600 | Boutignon | Sep 2003 | B2 |
6634362 | Conrad et al. | Oct 2003 | B2 |
6638284 | Rousseau et al. | Oct 2003 | B1 |
6716251 | Asius et al. | Apr 2004 | B1 |
6742524 | Knudson et al. | Jun 2004 | B2 |
6755868 | Rousseau | Jun 2004 | B2 |
6800082 | Rousseau | Oct 2004 | B2 |
6899105 | Krueger et al. | May 2005 | B2 |
6955172 | Nelson et al. | Oct 2005 | B2 |
6981944 | Jamiolkowski et al. | Jan 2006 | B2 |
7017582 | Metzger et al. | Mar 2006 | B2 |
7056331 | Kaplan et al. | Jun 2006 | B2 |
7135189 | Knapp | Nov 2006 | B2 |
7146981 | Knudson et al. | Dec 2006 | B2 |
7166570 | Hunter et al. | Jan 2007 | B2 |
7213599 | Conrad et al. | May 2007 | B2 |
7237554 | Conrad et al. | Jul 2007 | B2 |
7261702 | Alexandre et al. | Aug 2007 | B1 |
7288075 | Parihar et al. | Oct 2007 | B2 |
7297102 | Smith et al. | Nov 2007 | B2 |
7322993 | Metzger et al. | Jan 2008 | B2 |
7337781 | Vassallo | Mar 2008 | B2 |
7360432 | Lehtonen | Apr 2008 | B2 |
7360542 | Nelson et al. | Apr 2008 | B2 |
7367340 | Nelson et al. | May 2008 | B2 |
7401611 | Conrad et al. | Jul 2008 | B2 |
7442389 | Quelle et al. | Oct 2008 | B2 |
7601164 | Wu | Oct 2009 | B2 |
7669603 | Knudson et al. | Mar 2010 | B2 |
7806908 | Ruff | Oct 2010 | B2 |
7850894 | Lindh, Sr. et al. | Dec 2010 | B2 |
7857829 | Kaplan et al. | Dec 2010 | B2 |
7888119 | Sugaya et al. | Feb 2011 | B2 |
8142422 | Makower et al. | Mar 2012 | B2 |
8307831 | Rousseau | Nov 2012 | B2 |
8413661 | Rousseau et al. | Apr 2013 | B2 |
8632488 | Rousseau | Jan 2014 | B2 |
8800567 | Weadock et al. | Aug 2014 | B2 |
20010037133 | Knudson et al. | Nov 2001 | A1 |
20020144685 | Ivanovich et al. | Oct 2002 | A1 |
20030004579 | Rousseau et al. | Jan 2003 | A1 |
20030034312 | Unger et al. | Feb 2003 | A1 |
20030149445 | Knudson et al. | Aug 2003 | A1 |
20030149447 | Morency et al. | Aug 2003 | A1 |
20030149488 | Metzger et al. | Aug 2003 | A1 |
20030176875 | Anderson et al. | Sep 2003 | A1 |
20040020492 | Dubrul et al. | Feb 2004 | A1 |
20040020498 | Knudson et al. | Feb 2004 | A1 |
20040028676 | Klein et al. | Feb 2004 | A1 |
20040044366 | Bonutti et al. | Mar 2004 | A1 |
20040102796 | Hill et al. | May 2004 | A1 |
20040139975 | Nelson et al. | Jul 2004 | A1 |
20040144395 | Evans et al. | Jul 2004 | A1 |
20040147811 | Diederich et al. | Jul 2004 | A1 |
20040149290 | Nelson et al. | Aug 2004 | A1 |
20040153127 | Gordon et al. | Aug 2004 | A1 |
20040231678 | Fierro | Nov 2004 | A1 |
20050038472 | Furst | Feb 2005 | A1 |
20050082452 | Kirby | Apr 2005 | A1 |
20050092334 | Conrad et al. | May 2005 | A1 |
20050115572 | Brooks et al. | Jun 2005 | A1 |
20050121039 | Brooks et al. | Jun 2005 | A1 |
20050126563 | van de Burg et al. | Jun 2005 | A1 |
20050159637 | Nelson et al. | Jul 2005 | A9 |
20050165352 | Henry et al. | Jul 2005 | A1 |
20050199248 | Pflueger et al. | Sep 2005 | A1 |
20050203576 | Sulamanidze et al. | Sep 2005 | A1 |
20050251255 | Metzger et al. | Nov 2005 | A1 |
20050267321 | Shadduck | Dec 2005 | A1 |
20050267531 | Ruff et al. | Dec 2005 | A1 |
20050267532 | Wu | Dec 2005 | A1 |
20050267571 | Spence et al. | Dec 2005 | A1 |
20050268919 | Conrad et al. | Dec 2005 | A1 |
20050279365 | Armijo et al. | Dec 2005 | A1 |
20060005843 | Nelson et al. | Jan 2006 | A9 |
20060079935 | Kolster | Apr 2006 | A1 |
20060083767 | Deusch et al. | Apr 2006 | A1 |
20060093644 | Quelle et al. | May 2006 | A1 |
20060150986 | Roue et al. | Jul 2006 | A1 |
20060185673 | Critzer et al. | Aug 2006 | A1 |
20060206197 | Morsi | Sep 2006 | A1 |
20060207608 | Hirotsuka et al. | Sep 2006 | A1 |
20060207612 | Jackson et al. | Sep 2006 | A1 |
20060228391 | Seyedin et al. | Oct 2006 | A1 |
20060241339 | Cook et al. | Oct 2006 | A1 |
20060266369 | Atkinson et al. | Nov 2006 | A1 |
20060289015 | Boucher et al. | Dec 2006 | A1 |
20070000497 | Boucher et al. | Jan 2007 | A1 |
20070005109 | Popadiuk et al. | Jan 2007 | A1 |
20070005110 | Collier et al. | Jan 2007 | A1 |
20070102004 | Nelson et al. | May 2007 | A1 |
20070102010 | Lemperle et al. | May 2007 | A1 |
20070110788 | Hissong et al. | May 2007 | A1 |
20070119463 | Nelson et al. | May 2007 | A1 |
20070123996 | Sugaya et al. | May 2007 | A1 |
20070142700 | Fogarty et al. | Jun 2007 | A1 |
20070144531 | Tomas et al. | Jun 2007 | A1 |
20070144534 | Mery et al. | Jun 2007 | A1 |
20070144535 | Hegde et al. | Jun 2007 | A1 |
20070144539 | Dineen et al. | Jun 2007 | A1 |
20070190108 | Datta et al. | Aug 2007 | A1 |
20070204866 | Conrad et al. | Sep 2007 | A1 |
20070209665 | Gillis et al. | Sep 2007 | A1 |
20070227545 | Conrad et al. | Oct 2007 | A1 |
20070233276 | Conrad et al. | Oct 2007 | A1 |
20070246052 | Hegde et al. | Oct 2007 | A1 |
20070256693 | Paraschac et al. | Nov 2007 | A1 |
20070257395 | Lindh et al. | Nov 2007 | A1 |
20070261701 | Sanders | Nov 2007 | A1 |
20070267027 | Nelson et al. | Nov 2007 | A1 |
20070270631 | Nelson et al. | Nov 2007 | A1 |
20070272257 | Nelson et al. | Nov 2007 | A1 |
20070288057 | Kuhnel | Dec 2007 | A1 |
20070295338 | Loomas et al. | Dec 2007 | A1 |
20070295340 | Buscemi | Dec 2007 | A1 |
20080023012 | Dineen et al. | Jan 2008 | A1 |
20080035158 | Pflueger et al. | Feb 2008 | A1 |
20080035160 | Woodson et al. | Feb 2008 | A1 |
20080053461 | Dineen et al. | Mar 2008 | A1 |
20080066764 | Paraschac et al. | Mar 2008 | A1 |
20080066765 | Paraschac et al. | Mar 2008 | A1 |
20080066766 | Paraschac et al. | Mar 2008 | A1 |
20080066767 | Paraschac et al. | Mar 2008 | A1 |
20080066769 | Dineen et al. | Mar 2008 | A1 |
20080078411 | Buscemi et al. | Apr 2008 | A1 |
20080146868 | Henri Robert et al. | Jun 2008 | A1 |
20080167614 | Tolkowsky et al. | Jul 2008 | A1 |
20080199824 | Hargadon | Aug 2008 | A1 |
20080208265 | Frazier et al. | Aug 2008 | A1 |
20080221684 | Nelson et al. | Sep 2008 | A1 |
20080312688 | Nawrocki et al. | Dec 2008 | A1 |
20090025734 | Doelling et al. | Jan 2009 | A1 |
20090078411 | Kenison et al. | Mar 2009 | A1 |
20090165803 | Bhat et al. | Jul 2009 | A1 |
20090299472 | Huang | Dec 2009 | A1 |
20100023055 | Rousseau | Jan 2010 | A1 |
20100024830 | Rousseau et al. | Feb 2010 | A1 |
20100030011 | Weadock et al. | Feb 2010 | A1 |
20100037901 | Rousseau et al. | Feb 2010 | A1 |
20100049227 | Hegde et al. | Feb 2010 | A1 |
20100080791 | Rousseau et al. | Apr 2010 | A1 |
20100106246 | Rousseau et al. | Apr 2010 | A1 |
20100108077 | Lindh et al. | May 2010 | A1 |
20100132719 | Jacobs et al. | Jun 2010 | A1 |
20100137794 | Knudson et al. | Jun 2010 | A1 |
20100137905 | Weadock et al. | Jun 2010 | A1 |
20100158854 | Puisais | Jun 2010 | A1 |
20100163056 | Tschopp et al. | Jul 2010 | A1 |
20100211184 | Rousseau et al. | Aug 2010 | A1 |
20100234794 | Weadock et al. | Sep 2010 | A1 |
20100234946 | Rousseau | Sep 2010 | A1 |
20100256443 | Griguol | Oct 2010 | A1 |
20100294284 | Hohenhorst et al. | Nov 2010 | A1 |
20100319710 | Sharkawy et al. | Dec 2010 | A1 |
20110054522 | Lindh et al. | Mar 2011 | A1 |
20110100376 | Rousseau | May 2011 | A1 |
20110100377 | Weadock et al. | May 2011 | A1 |
20110100378 | Rousseau | May 2011 | A1 |
20110144558 | Rousseau | Jun 2011 | A1 |
20110174315 | Zhang et al. | Jul 2011 | A1 |
20110178439 | Irwin et al. | Jul 2011 | A1 |
20110238111 | Frank | Sep 2011 | A1 |
20110245850 | Cheng et al. | Oct 2011 | A1 |
20110282386 | Friedrich | Nov 2011 | A1 |
20120123449 | Schaller et al. | May 2012 | A1 |
20120160249 | Garrett | Jun 2012 | A1 |
20120245629 | Gross et al. | Sep 2012 | A1 |
20130074849 | Rousseau et al. | Mar 2013 | A1 |
20130098371 | Rousseau et al. | Apr 2013 | A1 |
20130103078 | Crovella et al. | Apr 2013 | A1 |
20130118505 | Rousseau et al. | May 2013 | A1 |
20130133669 | Rousseau | May 2013 | A1 |
20130150872 | Rousseau | Jun 2013 | A1 |
20130174857 | Rousseau et al. | Jul 2013 | A1 |
20130186412 | Weadock et al. | Jul 2013 | A1 |
20130319427 | Sung et al. | Dec 2013 | A1 |
Number | Date | Country |
---|---|---|
2465680 | Dec 2001 | CN |
201029957 | Mar 2008 | CN |
102198010 | Sep 2011 | CN |
102271624 | Dec 2011 | CN |
10245076 | Apr 2004 | DE |
2145587 | Jan 2010 | EP |
2386252 | Nov 2011 | EP |
2517633 | Oct 2012 | EP |
2651113 | Mar 1991 | FR |
7-500386 | Jan 1995 | JP |
11-514266 | Dec 1999 | JP |
2001-145646 | May 2001 | JP |
2003265621 | Sep 2003 | JP |
2005-529643 | Oct 2005 | JP |
2006-508708 | Mar 2006 | JP |
2006-517115 | Jul 2006 | JP |
2007-512090 | May 2007 | JP |
2007-313337 | Dec 2007 | JP |
2008-526286 | Jul 2008 | JP |
2008-529608 | Aug 2008 | JP |
2009-006090 | Jan 2009 | JP |
2010-017560 | Jan 2010 | JP |
2011-530385 | Dec 2011 | JP |
2005447 | Jan 1994 | RU |
2202313 | Apr 2003 | RU |
927236 | May 1982 | SU |
1697792 | Dec 1991 | SU |
WO 9713465 | Apr 1997 | WO |
WO 9900058 | Jan 1999 | WO |
WO 0066050 | Nov 2000 | WO |
WO 0121107 | Mar 2001 | WO |
WO 03075792 | Sep 2003 | WO |
WO 03096928 | Nov 2003 | WO |
WO 2004016196 | Feb 2004 | WO |
WO 2004020492 | Mar 2004 | WO |
WO 2004021869 | Mar 2004 | WO |
WO 2004021870 | Mar 2004 | WO |
WO 2004060311 | Jul 2004 | WO |
WO 2004084709 | Oct 2004 | WO |
WO 2004103196 | Dec 2004 | WO |
WO 2005046554 | May 2005 | WO |
WO 2005051292 | Jun 2005 | WO |
WO 2005082452 | Sep 2005 | WO |
WO 2005122954 | Dec 2005 | WO |
WO 2006012188 | Feb 2006 | WO |
WO 2006072571 | Jul 2006 | WO |
WO 2006108145 | Oct 2006 | WO |
WO 2007056583 | May 2007 | WO |
WO 2007075394 | Jul 2007 | WO |
WO 2007132449 | Nov 2007 | WO |
WO 2007134005 | Nov 2007 | WO |
WO 2007146338 | Dec 2007 | WO |
WO 2007149469 | Dec 2007 | WO |
WO 2008042058 | Apr 2008 | WO |
WO 2008063218 | May 2008 | WO |
WO 2008118913 | Oct 2008 | WO |
WO 2009023256 | Feb 2009 | WO |
WO 2009036094 | Mar 2009 | WO |
WO 2010019376 | Feb 2010 | WO |
WO 2010035303 | Apr 2010 | WO |
WO 2010051195 | May 2010 | WO |
WO 2010065341 | Jun 2010 | WO |
WO 2012004758 | Jan 2012 | WO |
WO 2012041205 | Apr 2012 | WO |
WO 2012064902 | May 2012 | WO |
WO 2012170468 | Dec 2012 | WO |
Entry |
---|
Notification of Transmittal of the International Search Report and the Written Opinion of the International Search Authority or the Declaration mailed on Feb. 3, 2010 for PCT/US2009/051921; International Filing Date: Jul. 28, 2009. |
Notification of Transmittal of the International Search Report and the Written Opinion of the International Search Authority or the Declaration mailed on May 25, 2010 for PCT/US2010/023152; International Filing Date: Apr. 2, 2010. |
International Search Report dated Nov. 4, 2009 for International Patent Application No. PCT/US2009/052126. |
International Search Report dated Dec. 21, 2009 for International Patent Application No. PCT/US2009/057661. |
International Search Report dated Dec. 22, 2009 for International Patent Application No. PCT/US2009/061223. |
International Search Report dated Dec. 29, 2009 for International Patent Application No. PCT/US2009/061455. |
International Search Report dated Jan. 21, 2010 for International Patent Application No. PCT/US2009/052110. |
International Search Report dated Apr. 29, 2010 for International Patent Application No. PCT/US2009/065293. |
International Search Report dated May 25, 2010 for International Patent Application No. PCT/US2010/023152. |
International Search Report dated May 25, 2010 for International Patent Application No. PCT/US2010/025778. |
International Search Report dated Jan. 14, 2011 for International Patent Application No. PCT/US2010/052628. |
International Search Report dated Jan. 20, 2011 for International Patent Application No. PCT/US2010/052644. |
International Search Report dated Jan. 24, 2011 for International Patent Application No. PCT/US2010/052649. |
International Search Report dated Feb. 28, 2011 for International Patent Application No. PCT/US2010/059673. |
International Search Report dated Apr. 9, 2013 for International Patent Application No. PCT/US2012/061569. |
International Search Report dated Apr. 2, 2013 for International Patent Application No. PCT/US2012/067708. |
International Search Report dated Oct. 2, 2013 re: PCT/US2013/043238. |
International Search Report dated May 24, 2013 for International Patent Application No. PCT/US2012/066011. |
Written Opinion dated Nov. 27, 2012 for International Patent Application No. PCT/US2012/056577. |
MacMillan Dictionary, Fiber, MacMillan Publisher, Limited 2009-2014. |
International Search Report re: PCT/US2012/0565677 dated Nov. 27, 2012. |
International Preliminary Report on Patentability dated Feb. 15, 2011 for International Patent Application No. PCT/US2009/051921. |
International Preliminary Report on Patentability dated Apr. 1, 2014 for International Patent Application No. PCT/US2012/056577. |
International Preliminary Report on Patentability dated Jun. 10, 2014 for International Patent Application No. PCT/US2012/067708. |
International Preliminary Report on Patentability dated Dec. 2, 2014 for International Patent Application No. PCT/US2013/043238. |
International Search Report dated Mar. 2, 2010 for International Patent Application No. PCT/US2009/051921. |
Cole et al., “Snoring: A Review and a Reassessment”, J. of Otolaryngology, vol. 24, No. 5 pp. 303-306 (1995). |
Database WPI Week 198312, Thomson Scientific, London, GB; AN 1983-D9513K XP002693421, -& SU 927 236 A1 (Petrozazodsk Univ) May 15, 1982 abstract (see figures 7 & 8). |
Friedman et al., “A System and Method for Inserting a Medical Device for Treatment of Sleep Apnea via the Nasal Passage, and Device Therefor”, Dec. 29, 2008, U.S. Appl. No. 61/203,758, p. 8 & p. 6/8. |
Harries et al., “The Surgical treatment of snoring”, J. of Laryngology and Otology, vol. 110, Issue 12 pp. 1105-1106 (1996). |
Huang et al., “Biomechanics of snoring”, Endeavour, vol. 19(3): pp. 96-100 (1995). |
Medtronic AIRvance System for Obstructive Sleep Apnea. http.//www.medtronic.com/for-healthcare-professionals/products-therapies/ear-nose-throat/sleep-disordered-breathing-products/airvance-system-for-obstructive-sleep-apnea/index.htm. |
Pang, Kenny et al., “Tongue Suspension Suture in Obstructive Sleep Apnea”, Operative Techniques in Otolaryngology, vol. 17, No. 4, pp. 252-256 (2006). |
Repose Genioglossus Advancement, INFLUENT Medical, www.influ-ent.com, 1 page (2008). |
Schleef et al., “Cytokine Activation of Vascular Endothelium, Effects on Tissue-Type 1 Plasminogen Activator Inhibitor” The J. of Biological Chem., vol. 263, No. 12, pp. 5797-5803 (1988). |
Schwab et al., “Upper airway and soft tissue changes induced by CPAP in normal subject”, Am. J. Respit. Crit. Care Med., vol. 154, No. 4 pp. 1106-1116 (1996). |
Schwartz et al., “Effects of electrical stimulation to the soft palate on snoring and obstructive sleep apnea”, J. Prosthetic Dentistry, vol. 76 pp. 273-281 (1996). |
Shamsuzzaman et al., “Obstructive Sleep Apnea; Implications for Cardiac and Vascular Disease”, JAMA vol. 290, No. 14 pp. 1906-1914 (2003). |
Teles et al., “Use of Palatal Lift Prosthesis on Patient Submitted to Maxillectomy: A Case Report”, Applied Cancer Res. vol. 25(3), pp. 151-154 (2005). |
The Advance System, Aspire Medical, Inc. www.aspiremedical.com, 3 pp (2008). |
The Pillar Procedure, Restore Medical, Inc. www.restoremedical.com, 2 pp (2008). |
Vicente et al., “Tongue-Base Suspension in Conjunction with Uvulopapatopharyngoplasty for Treatment of Severe Obstructive Sleep Apnea: Long-term Follow-Up Results”, The Laryngoscope, vol. 116 pp. 1223-1227 (2006). |
Wassmuth et al., “Cautery-assisted palatal stiffening operation for the treatment of obstructive sleep apnea syndrome”, Otolaryngology—Head and Neck Surgery, vol. 123, pp. 55-60 (2000). |
Wiltfang et al., “First results on daytime submandibular electrostimulation of suprahyoidal muscles to prevent night-time hypopharyngeal collapse in obstructive sleep apnea syndrome”, Intl J. of Oral & Maxillofacial Surgery vol. 28 pp. 21-25 (1999). |
International Preliminary Report on Patentability dated Feb. 1, 2011 for International Patent Application No. PCT/US2009/052110. |
International Preliminary Report on Patentability dated Feb. 1, 2011 for International Patent Application No. PCT/US2009/052126. |
International Preliminary Report on Patentability dated Apr. 26, 2011 for International Patent Application No. PCT/US2009/061223. |
International Preliminary Report on Patentability dated May 3, 2011 for International Patent Application No. PCT/US2009/061455. |
International Preliminary Report on Patentability dated Jun. 7, 2011 for International Patent Application No. PCT/US2009/065293. |
International Preliminary Report on Patentability dated Aug. 23, 2011 for International Patent Application No. PCT/US2010/023152. |
International Preliminary Report on Patentability dated Sep. 20, 2011 for International Patent Application No. PCT/US2010/025778. |
International Preliminary Report on Patentability dated May 1, 2012 for International Patent Application No. PCT/US2010/052628. |
International Preliminary Report on Patentability dated May 1, 2012 for International Patent Application No. PCT/US2010/052644. |
International Preliminary Report on Patentability dated May 1, 2012 for International Patent Application No. PCT/US2010/052649. |
International Preliminary Report on Patentability dated Jun. 19, 2012 for International Patent Application No. PCT/US2010/059673. |
International Preliminary Report on Patentability dated Apr. 29, 2014 for International Patent Application No. PCT/US2012/061569. |
International Preliminary Report on Patentability dated Jun. 3, 2014 for International Patent Application No. PCT/US2012/066011. |
Nordgard, S. et al ‘One-year results: palatal implants for the treatment of obstructive sleep apnea’ Otolaryngology Head Neck Surg. May 2007; 136(5): 818-22. |
Number | Date | Country | |
---|---|---|---|
20140261452 A1 | Sep 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13247713 | Sep 2011 | US |
Child | 14291784 | US |